The cellular immunotherapy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cellular Immunotherapy Market, 2024 report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size -
The cellular immunotherapy market size has grown rapidly in recent years. It
will grow from $4.99 billion in 2023 to $5.78 billion in 2024 at a compound
annual growth rate (CAGR) of 15.9%. The growth in the historic period can be
attributed to cancer treatment advancements, clinical success stories,
regulatory approvals, growing incidence of targeted diseases.
The cellular immunotherapy market size is expected to see rapid growth in the
next few years. It will grow to $9.95 billion in 2028 at a compound annual
growth rate (CAGR) of 14.6%. The growth in the forecast period can be
attributed to expansion to solid tumors, improved manufacturing, healthcare
infrastructure, research funding. Major trends in the forecast period include
research and development investments, clinical trial data, combination
therapies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report
Scope Of Cellular Immunotherapy Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Cellular Immunotherapy Market Overview
Market Drivers -
Increasing research and successful clinical trials in cellular immunotherapy
are expected to drive the growth of the cellular immunotherapy market over the
forecast period. Companies are focusing on developing new cellular
immunotherapies for treating different diseases. For instance, in June 2022,
according to a report published by the Cancer Research Institute, a US-based
nonprofit organization devoted solely to developing immunotherapy for the
prevention, treatment, and eventual eradication of all cancers, in the
worldwide immuno-oncology pipeline as of April 2022, there were 2,756 active
cell therapy drugs, up 36% from the landscape analysis of 2021 that revealed
2,031 such agents but also a slight slowdown from the 43% growth in the
previous year. The rapid growth in the development of cellular immunotherapy in
clinical and preclinical stages in 2020 as compared to that in 2019 is
projected to expand the landscape of cellular immunotherapy. Subsequently,
generating higher revenues for the growth of the cellular immunotherapy market.
Market Trends -
Companies in the cellular immunotherapy market are focusing on developing
off-the-shelf allogeneic therapies for new and improved cancer treatment.
Off-the-shelf allogeneic therapies are produced from the cells of donors
instead of the patient's cells, as in the case of autologous therapy. Their
non-customized nature provides advantages such as cost-effectiveness, large
scale, fast production, and quality control. For instance, in May 2022,
Novartis AG, a Switzerland-based pharmaceutical company specializing in the
discovery, development, manufacturing, and commercialization of drugs,
announced that after two or more lines of systemic therapy, the US Food and
Drug Administration (FDA) has given expedited approval for Kymriah
(tisagenlecleucel) to treat adult patients with relapsed or refractory (r/r)
follicular lymphoma (FL). In addition, Acepodia, a US-based next-generation
cell immuno-technology company, will begin a phase 1 clinical trial in August
2020 to evaluate ACE1702, an allogeneic, off-the-shelf NK cell therapy, for the
treatment of solid tumors.
The cellular immunotherapy market covered in this report is segmented –
1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell
Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural
Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell
Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer,
Brain Tumour, Lung Cancer, Other Applications
Get an inside scoop of the cellular immunotherapy market, Request now for
Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp
Regional Insights -
North America was the largest region in the cellular immunotherapy market in
2023. The regions covered in the cellular immunotherapy market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa
Key Companies -
Major companies operating in the cellular immunotherapy market include Novartis
International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals
LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers
Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc.,
ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson,
Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc.,
Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio
Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics
Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR
Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas
Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego
Corporation
Table of Contents
1. Executive Summary
2. Cellular Immunotherapy Market Report Structure
3. Cellular Immunotherapy Market Trends And Strategies
4. Cellular Immunotherapy Market – Macro Economic Scenario
5. Cellular Immunotherapy Market Size And Growth
…..
27. Cellular Immunotherapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment